Company page

Beam Therapeutics Inc.

Beam Therapeutics Inc. is a public biotechnology company based in the United States, trading under the ticker BEAM. The company focuses on developing precision genetic medicines using its proprietary base editing technology. As of now, Beam Therapeutics has a market capitalization of approximately $3.51 billion.